MARKET

VRCA

VRCA

Verrica Pharmaceuticals
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.91
+0.03
+0.19%
After Hours: 15.91 0 0.00% 16:00 01/17 EST
OPEN
15.97
PREV CLOSE
15.88
HIGH
16.20
LOW
15.60
VOLUME
60.56K
TURNOVER
--
52 WEEK HIGH
18.67
52 WEEK LOW
6.84
MARKET CAP
396.90M
P/E (TTM)
-15.0194
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VRCA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VRCA News

  • Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102
  • GlobeNewswire.2d ago
  • Pacira's (PCRX) Exparel Meets Key Goals in C-Section Study
  • Zacks.01/08 16:16
  • Verrica's NDA Acceptance By FDA For VP-102 May Allow It To Enter Untapped Market
  • Seeking Alpha - Article.12/22/2019 12:21
  • Is Verrica Pharmaceuticals Inc. (VRCA) A Good Stock To Buy?
  • Insider Monkey.11/29/2019 03:43

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About VRCA

Verrica Pharmaceuticals Inc. is a United States-based clinical-stage medical dermatology company. The Company is focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its lead product candidate, VP-102, is a drug-device combination of topical solution of cantharidin. The Company also intends to develop second cantharidin-based product candidate, VP-103, for the treatment of plantar warts. The Company has completed one Phase II clinical trial of topical solution of cantharidin administered with the wooden stick part of a cotton-tipped swab. It also conducting another Phase II clinical trial of topical solution of cantharidin administered through applicator, which collectively refer to as VP-102, for the treatment of molluscum.
More

Webull offers Verrica Pharmaceuticals Inc (VRCA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.